ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1456	National Cancer Institute	Html	en	Vulvar Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of vulvar cancer.	lesion-type VIN grade 0.488217 radiation therapy arm 0.777718 vulvar surgical procedures 0.466679 sentinel node dissection 0.727156 Radiation Therapy section 0.586061 case series 0.468674 groin dissection study 0.616489 vulvar cancer 0.538035 positive sentinel nodes 0.479331 lymph node dissection 0.680638 sentinel node identification. 0.538816 invasive vulvar cancer 0.471336 vulvar cancer-related deaths 0.462293 radiation therapy issue 0.483522 clinically localized vulvar 0.482117 node dissection 0.932807 bloc inguinal node 0.506403 sentinel node dissections 0.642236 bilateral groin node 0.587002 Actuarial groin recurrence 0.544605 groin lymph 0.484094 pelvic node resection 0.498834 radical vulvectomy 0.489162 sentinel node 0.79935	high-grade vin 0.507503 bilateral dissection 0.465866 groin dissection arm 0.620835 invasive locoregional vulvar 0.48636 sentinel node procedures 0.539343 groin recurrence 0.545931 groin dissection 0.6467 femoral lymph node 0.521493 negative sentinel node 0.528158 negative sentinel nodes 0.475577 patients 0.605395 groin-node dissection 0.464 inguinal node dissection 0.663124 groin node dissection 0.784008 ipsilateral inguinal node 0.504912 pelvic radiation 0.458909 Node metastases 0.461128 groin node-positive disease 0.523738 groin radiation 0.532254 regional lymph nodes 0.463891 HPV 6/11-associated vulvar 0.461386 negative groin nodes 0.546977 systematic literature review 0.508112	CLICK HERE
1553	National Cancer Institute	Html	en	Childhood Non-Hodgkin Lymphoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of childhood non-Hodgkin lymphoma.	cancer treatment 0.41722 Burkitt-like non-Hodgkin lymphoma 0.414505 panniculitis-like T-cell lymphoma 0.407586 mediastinal B-cell lymphoma 0.477834 type 0.421123 body 0.397298 childhood non-hodgkin lymphoma 0.888605 PDQ cancer information 0.389516 Non-Hodgkin Lymphoma Treatment 0.431482 clinical trial search 0.395907 B-cell non-Hodgkin lymphoma 0.444319 gamma-delta T-cell lymphoma 0.40789 clinical trials 0.596027 large cell lymphoma 0.576342 peripheral t-cell lymphoma 0.4403 clinical trial 0.545942 stem cell transplant 0.416614 Burkitt lymphoma 0.412037 anaplastic lymphoma kinase 0.405034 primary mediastinal b-cell 0.402494 diffuse large b-cell 0.419339 lymph nodes 0.504405 Pediatric-type follicular lymphoma 0.401311 large B-cell lymphoma 0.505692	radiation therapy 0.400696 childhood hodgkin lymphoma 0.422956 treatment 0.602592 Hodgkin Lymphoma Treatment 0.428936 cutaneous t-cell lymphoma 0.531706 cancer cells 0.482982 Burkitt-like lymphoma /leukemia 0.41493 HIV-related non-Hodgkin lymphoma 0.410943 certain gene changes 0.416336 Adult Non-Hodgkin Lymphoma 0.452762 recurrent lymphoblastic lymphoma 0.388804 lymphoblastic lymphoma 0.418163 follicular lymphoma 0.416701 combination chemotherapy 0.479578 non-hodgkin lymphoma 0.995932 bone marrow 0.469909 marginal zone lymphoma 0.455485 cells 0.53075 cancer clinical trials 0.407298 lymph node 0.390457 treatment options 0.51667 anaplastic large cell 0.523091 HIV-associated non-Hodgkin lymphoma 0.431952 cancer 0.673011	CLICK HERE
1559	National Cancer Institute	Html	en	Endometrial Cancer Screening (PDQ®)–Patient Version	Expert-reviewed information summary about tests used to detect or screen for endometrial cancer.	cancer treatment 0.561966 Pap test results 0.564545 ongoing clinical trials 0.564273 following PDQ summaries 0.605267 PDQ cancer information 0.713937 false-negative test result 0.559289 Uterine Sarcoma Treatment 0.562863 uterus 0.565825 Endometrial sampling 0.614718 clinical trials 0.686375 test result 0.59341 transvaginal ultrasound 0.592257 cancer information summary 0.653614 clinical trial 0.570758 test results 0.593938 breast cancer prevention 0.577475 false-positive test result 0.559048 latest published information 0.566054 PDQ® Screening 0.557798 NCI’s PDQ 0.572282 cancer symptoms 0.57367 NCI PDQ cancer 0.624163 tests 0.615659 black women 0.581998	PDQ Screening 0.598441 treatment 0.572654 cancer prevention 0.577647 screening tests 0.574176 cancer cells 0.559463 endometrial cancer screening 0.701539 Cancer Information Service 0.589993 Prevention Editorial Board 0.603972 treatment clinical trials 0.562297 National Cancer Institute 0.661886 endometrial cancer 0.979643 PDQ documents 0.56725 new treatment 0.567011 Cancer screening trials 0.628138 Cancer Care page 0.581539 PDQ database 0.570002 breast cancer 0.579583 abnormal vaginal bleeding 0.663193 non-polyposis colon cancer 0.588586 risk factor 0.558033 PDQ summary 0.615448 yearly screening 0.56313 cancer information summaries 0.594869 comprehensive cancer information 0.595413	CLICK HERE
1836	National Cancer Institute	Html	es	Tratamiento de la leucemia mieloide aguda y otras neoplasias mieloides malignas infantiles (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de la leucemia mieloide aguda infantil, síndromes mielodisplásicos y otras neoplasias mieloproliferativas.	frecuencia mutaciones 0.438095 LMA familiares 0.551304 leucemia eritroidea aguda 0.449843 American Academy 0.418016 Leucemia aguda eritroidea 0.453243 gen runx1t1 0.417024 neoplasias mieloides 0.421266 transient leukemia 0.421355 Sin embargo 0.442991 gen crebbp 0.417273 LMA ayuda 0.492779 necesarias mutaciones 0.436351 leucemia mielomonocítica aguda 0.45265 Panmielosis aguda 0.424398 subtipo fab 0.419671 leucemias mieloides 0.437133 Leucemia basofílica aguda 0.453074 leucemia mielógena 0.434701 Children's Oncology Group 0.430324 gen etv6 0.41685 leucemia transitoria 0.433759 reordenamiento leucemia aguda 0.452795 Leucemia megacarioblástica aguda 0.453115 Smith MA 0.431884 Leucemia aguda mielomonocítica 0.453529	gen evi1 0.417889 leucemia promielocítica aguda 0.56535 Organización Mundial 0.42957 gen mll 0.697325 células madre 0.41719 leucemia aguda 0.953312 LMA M0 0.546818 leucemia linfoblástica aguda 0.491741 SAI Leucemia 0.451225 tipo ii 0.459931 gen runx1 0.418208 Pediatr Blood Cancer 0.433879 gen cbf-beta 0.418127 M0 LMA 0.495335 leucemia monocítica aguda 0.501087 fraterno presente leucemia 0.436812 linaje mieloide 0.448127 leucemias bifenotípicas mieloides 0.422616 leucemia megacariocítica aguda 0.525006 leucemia mieloblástica aguda 0.537614 BCR-ABL1 Leucemia aguda 0.451622 leucemia mieloide aguda 0.756372 linaje linfoide 0.423692 La traslocación 0.522981	CLICK HERE
1890	National Cancer Institute	Html	es	Tratamiento del cáncer de seno (mama) (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de seno (mama).	estadio lllC 0.524041 siguientes procedimientos 0.510716 siguientes aspectos 0.534365 causa efectos 0.516747 estadio lllB 0.524512 estadio lllA 0.524967 rayos x 0.508877 causó hinchazón 0.508591 cuáles lesiones 0.508991 Breast Cancer Risk 0.519727 epidérmico humano tipo 0.51911 carcinoma lobulillar 0.618686 crecimiento llamada her2 0.513006 cuerpo llamada ecograma 0.530459 pared torácica.ampliar mastectomía 0.517551 siguientes estadios 0.514163 proteína tipo factor 0.510936 células madre 0.671831 estadio iv 0.594708 ganglio linfático centinela 0.990128 Oncotype DX 0.510563 estadio ib 0.547143 prueba ayuda 0.524997 enlace drugs approved 0.56421 estadio ia 0.546556	mama.ampliar cirugía 0.509968 CLIS.Ampliar Carcinoma lobulillar 0.520349 efectos tardíos 0.515275 proteína her2 0.510017 Características genéticas 0.510197 bulbos minúsculos 0.511767 Breast Cancer Treatment 0.519669 cuántos genes 0.511329 incisión separada.ampliar mastectomía 0.517497 estadio iiia 0.543785 antecedentes familiares 0.532316 cabo pruebas 0.51404 estadio iiic 0.596075 estadio llB 0.525023 estadio llA 0.525437 Gynecologic Cancers 0.511174 mama.ampliar mamografía 0.511179 proteína llamada mTOR 0.510238 Breast Cancer 0.623769 sección cáncer 0.744984 pequeñas llamadas lobulillos 0.518854 genes brca1 0.512161 siguientes pruebas 0.535819 siguientes sumarios 0.517679	CLICK HERE
2002	National Cancer Institute	Html	es	Tratamiento del feocromocitoma y paraganglioma (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del feocromocitoma y paraganglioma.	associated with 0.440801 paraganglioma hereditario sdhd 0.442898 Surg Oncol Clin 0.439027 Gimenez-Roqueplo AP 0.438768 Chatellier G 0.438739 patients with apparently 0.435891 with von hippel-lindau 0.426826 evaluation following resection 0.43956 gastric stromal sarcoma 0.435317 Carney JA 0.479643 hereditary paraganglioma 0.424404 gland scaled score 0.43937 Clin Proc 0.426209 effective treatment with 0.472522 secondary hypertension 0.431368 Neuroendocrine Neoplasias 0.453768 extra-adrenal paraganglioma 0.447147 von hippel-lindau 0.471522 feocromocitoma síndrome 0.499112 patients with 0.828258 Clin Endocrinol Metab 0.986823 Young WF Jr 0.474746 or secreting 0.439481 Servais A 0.436374 patients with metastatic 0.46137	Surg Pathol 0.438013 hypertension persistence after 0.484322 adrenal gland scaled 0.443509 Fofol I 0.439495 Feocromocitoma Opciones estándar 0.480462 Endocrinol Metab Clin 0.443246 feocromocitoma metastásico cirugía 0.494173 during pregnancy 0.424683 feocromocitoma-paraganglioma familiar tipo 0.517532 Long-term evaluation following 0.440068 endocrina múltiple tipo 0.439079 Pacak K 0.437715 Heerden JA 0.443555 with combination chemotherapy 0.426625 Intern Med 0.453092 autosomal dominant paraganglioma 0.427278 Clin Oncol 0.478285 extra suprarrenales surgen 0.434497 extra suprarrenales 0.652785 carney triad 0.424742 feocromocitoma regional cirugía 0.492979 parasimpáticos extra suprarrenales 0.431253 associated with sdhb 0.428378 familial paraganglioma 0.44151	CLICK HERE
2053	National Cancer Institute	Html	es	Vacunas contra los virus del papiloma humano	Una hoja informativa acerca de las vacunas contra los virus del papiloma humano (VPH) para prevenir infecciones con ciertos tipos de VPH, los cuales son la causa principal del cáncer de cuello del útero o cérvix.	HPV prophylactic vaccines 0.314226 hpv vaccine 0.332876 Lancet Oncology 0.308843 with preexisting infection 0.306342 Mortality Weekly Report 0.31501 bivalent hpv vaccination 0.314902 largo plazo 0.306588 Disease Control 0.307862 genital warts among 0.306064 clinical trial 0.315859 anal hpv 0.312394 Estados Unidos 0.376477 hpv vaccination 0.357231 Hariri S 0.317621 Rica Vaccine Trial 0.314539 PubMed Abstract 0.885463 human papillomavirus 0.614779 vacunas gardasil® 0.319024 Infectious Diseases 0.318629 quadrivalent hpv 0.312783 Chaturvedi AK 0.307922 BMC Infectious Diseases 0.305886 hpv infection 0.324228 Hildesheim A 0.314688 Feng Q 0.308321	among young 0.314298 papillomavirus acquisition 0.305662 United States 0.307989 alto riesgo 0.531462 Updated HPV Vaccination 0.328083 British Medical Journal 0.305646 HPV Vaccination Recommendations 0.328083 Costa Rica 0.313988 Immunization Practices 0.308391 Advisory Committee 0.307786 papillomavirus among 0.306019 infecciones persistentes.  gardasil 0.336098 9-valent human papillomavirus 0.32439 papillomavirus prophylactic vaccines 0.30978 Bocchini JA 0.307795 ¿Cuáles cánceres 0.312957 Hughes JP 0.308264 bivalent hpv 0.331056 cuello uterino 0.992097 Vaccine Safety Datalink 0.314052 genital hpv infection 0.315334 Cancer Institute 0.307587 New England Journal 0.348895 Petrosky E 0.307326	CLICK HERE
3653	National Cancer Institute	Html	es	Cannabis y canabinoides (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso del Cannabis y canabinoides para el tratamiento de los efectos secundarios relacionados con el tratamiento del cáncer como la náusea y el vómito.	suficiente información 0.303746 American Academy 0.304933 salud masculina 0.30438 Controlled Substances Act 0.309374 estado.ampliar mapa 0.305022 NCI Best Case 0.309795 Ley Boggs 0.304951 ratones modelo 0.329727 Asia central 0.304897 datos bibliográficos pubmed 0.306457 principal canabinoide 0.317402 continuas preocupaciones 0.305444 Instituto Nacional 0.356831 distintos métodos 0.304585 Salud Complementaria 0.311676 Asociación Médica Americana 0.308343 complementarias revisa 0.305401 huésped aguda 0.30517 posibles efectos 0.307656 siglo xix 0.305316 Estados Unidos 0.923075 Investigational New Drug 0.308776 ¿Los beneficios 0.303644 Centro Nacional 0.308445 células madre 0.307765	New Hampshire Avenue 0.305866 creciente interés 0.305364 Drug Administration 0.303686 vía oral 0.438627 medicamentos canabinoides 0.315665 lista i 0.304143 Marijuana Tax Act 0.30965 Men's Health Study 0.308077 siguientes riesgos 0.303989 suficientes pruebas 0.305693 Visuals Online 0.304212 sistema nervioso central 0.330645 Physician Data Query 0.323581 libre uso 0.304331 principal ingrediente 0.304814 receptores canabinoides 0.313898 posibles beneficios 0.304408 página manejo 0.303972 ¿El tratamiento 0.309063 planta cannabis 0.341326 potencial alto 0.304956 medicina complementaria 0.465284 largo tiempo 0.303689 ¿el cannabis 0.355862	CLICK HERE
15738	National Cancer Institute	Html	en	Financial Toxicity and Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the risk of experiencing financial difficulty during cancer treatment.	adult cancer survivors 0.29753 cancer treatment 0.260149 study 0.333877 high out-of-pocket spending 0.29174 health insurance 0.332995 newly diagnosed cancer 0.254116 out-of-pocket cost burden 0.275794 financial hardship 0.814372 colorectal cancer patients 0.270243 colorectal cancer survivors 0.274934 economic burden 0.33821 higher out-of-pocket spending 0.308086 Support Care Cancer 0.263278 material financial hardship 0.310411 Cancer Care Outcomes 0.299421 high out-of-pocket costs 0.25691 health care 0.364957 out-of-pocket health care 0.305633 higher out-of-pocket costs 0.256873 high out-of-pocket burden 0.326935 State cancer patients 0.282656 cancer care 0.417219 personal financial burden 0.365783 lung cancer patients 0.262392	ongoing cancer care 0.28258 colorectal cancer 0.3351 cancer patients 0.489203 Clin Oncol 0.334879 comprehensive cancer center 0.290609 cancer-related financial burden 0.257868 cancer diagnosis 0.320181 later financial hardship 0.252008 Long-term financial burden 0.276409 financial distress 0.563858 out-of-pocket spending 0.410176 breast cancer survivors 0.328299 financial burden 0.630038 out-of-pocket costs 0.285058 greater financial burden 0.273818 financial toxicity 0.49873 cancer survivors 0.880073 advanced-stage cancer patients 0.289755 high financial burden 0.284717 cancer 0.949444 substantial financial hardship 0.256681 risk 0.255869 cancer history 0.289124	CLICK HERE
16684	National Cancer Institute	Html	en	Immunotherapy	Immunotherapy is treatment that helps your immune system fight cancer. Get information about the different types of immunotherapy and what you can expect during treatment.	different ways 0.281527 fatal allergic reactions 0.264895 Certain immunotherapies 0.259316 treatment vaccines 0.275288 cancer cells 0.951751 new healthy cells 0.412417 type 0.312586 adult cancer treatment 0.355067 immune system fight 0.336993 cancer treatment summaries 0.489214 body’s cells 0.328519 white blood cells 0.50706 immune response 0.442108	bladder cancer 0.215882 immunotherapy 0.916869 car t-cell therapy 0.510597 white blood cell 0.291068 biological therapy 0.305661 immune cells 0.541167 normal immune responses 0.430369 immunotherapies 0.36897 different types 0.290719 early skin cancer 0.309312 body fight infections 0.317237 childhood cancer treatment 0.34975 adoptive cell transfer 0.589329	CLICK HERE